CASTRATION RESISTANT METASTATIC PROSTATE CANCER
Clinical trials for CASTRATION RESISTANT METASTATIC PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION RESISTANT METASTATIC PROSTATE CANCER trials appear
Sign up with your email to follow new studies for CASTRATION RESISTANT METASTATIC PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a testosterone boost help fight resistant prostate cancer?
Disease control Recruiting nowThis study is for men with advanced prostate cancer that has stopped responding to standard hormone therapy but who are not yet in pain. It compares two treatments: taking the drug enzalutamide alone versus taking it along with cycles of high-dose testosterone. The goal is to see…
Matched conditions: CASTRATION RESISTANT METASTATIC PROSTATE CANCER
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New radioactive drug targets tough prostate cancer in early trial
Disease control Recruiting nowThis early-phase study tests a new radioactive drug called [225Ac]Ac-AKY-2519 in people with a hard-to-treat type of advanced prostate cancer (metastatic castration-resistant prostate cancer). The drug targets a protein (B7-H3) on cancer cells to deliver radiation directly to tum…
Matched conditions: CASTRATION RESISTANT METASTATIC PROSTATE CANCER
Phase: PHASE1 • Sponsor: Aktis Oncology, Inc. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New study aims to predict which prostate cancer patients benefit from Lu-PSMA therapy
Knowledge-focused Recruiting nowThis study is looking for genetic clues in tumor tissue that could help doctors know ahead of time whether Lu-PSMA treatment will work for men with advanced, castration-resistant prostate cancer. About 120 men who have already tried other treatments will provide tumor samples for…
Matched conditions: CASTRATION RESISTANT METASTATIC PROSTATE CANCER
Phase: NA • Sponsor: Centre Jean Perrin • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC